๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Gastric Cancer (GC)
Clinical trial register · China

Gastric Cancer (GC) Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Nanjing 4 Beijing 4 Jinan 3 Tianjin 2 Wuxi 2
Narrow the registerReset
Recruitment status
Phase
Site location
Nanjing4 Beijing4 Jinan3 Tianjin2 Wuxi2
All 27 locations
Target enrolment
to

Gastric Cancer (GC) trials in China

23 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Chemoradiotherapy and SHR-1701 in Patients With Unresectable Gastric Cancer
NCT07689851Gastric Cancer (GC), Gastroesophageal Junction Adenocarcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
60
Shenzhen, Taiyuan, Beijing
2026-07-01
Not yet open
TEAS Timing for Gastrectomy Recovery (TEAS-TIME Trial)
NCT07714980Gastric Cancer (GC), Stomach Neoplasms
The Affiliated Hospital of Qingdao University
Not applicable
300
Dongying, Qingdao, Rizhao, Weifang, Weihai, Yantai
2026-07
Not yet open
A Study on the Efficacy of Sodium Propionate Combined With Anti-PD-1 Immunotherapy in Gastric Cancer
NCT07615907Gastric Cancer (GC)
Jinling Hospital, China
Not applicable
20
Nanjing
2026-05-30
Active, closed
Beta-Blockers on Neoadjuvant Immunochemotherapy for Hypertensive Patients With Gastric Cancer
NCT07622693Gastric Cancer (GC)
Nanfang Hospital, Southern Medical University
Observational
80
Guangzhou
2026-05-10
Recruiting
Comparison of Double-tract and Tubular Gastric Anastomosis in Proximal Gastric Cancer
NCT07635836Gastric Cancer (GC), Double-tract Reconstruction, Tubular Gastric Anastomosis
Qilu Hospital of Shandong University
Not applicable
52
Jinan
2026-05-01
By invitation
Early Postoperative Intervention in Gastric Cancer Patients
NCT07444099Gastric Cancer (GC), Postoperative Recovery
Qilu Hospital of Shandong University
Not applicable
264
Jinan
2026-02-10
Recruiting
Multimodal AI for Predicting Response to Neoadjuvant Immunotherapy in Gastric Cancer (PRISM-GC)
NCT07401199Gastric Cancer (GC), Locally Advanced Gastric Cancer
Qun Zhao
Observational
2,000
Fuyang, Cangzhou, Hengshui, Xingtai, Wuhan, Yichang, Baoding, Shijiazhuang
2026-02-05
Not yet open
Robotic vs Laparoscopic Gastrectomy for cT4a Gastric Cancer
NCT07331454Gastric Cancer (GC)
The First Affiliated Hospital with Nanjing Medical University
Phase 3
335
Nanjing
2026-02-01
Recruiting
SHR-1701 + Rivoceranib (ยฑ SHR-2554) in Advanced GC After First-Line Immunotherapy Failure
NCT07311408Gastric Cancer (GC), Gastroesophageal Junction Adenocarcinoma
Jingdong Zhang
Phase 2
40
Shenyang
2026-01-01
Recruiting
Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric Cancer
NCT07366528Gastric Cancer (GC), Adjuvant Chemotherapy, Stage 3 Cancer, Docetaxel
Ruijin Hospital
Phase 3
387
Shaoguan, Shanghai
2025-12-15
Recruiting
Iparomlimab and Tuvonralimab (QL1706) Combined With Chemotherapy for Previously Untreated Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer
NCT07315854Gastric Cancer (GC), Gastroesophageal Junction Cancer, Advanced Gastric Cancer, Metastatic Gastric Cancer
Beijing Friendship Hospital
Phase 2
32
Beijing
2025-11-04
Not yet open
Safety and Efficacy of NK510 to Treat Gastric Cancer and Colorectal Cancer
NCT07166263Gastric Cancer (GC), Colorectal Cancer
Base Therapeutics (Shanghai) Co., Ltd.
Phase EARLY_PHASE1
15
Nanjing
2025-11
Not yet open
Clinical Application of PET Imaging Targeting GPA33 in Malignant Tumors
NCT07172503Colorectal Cancer, Gastric Cancer (GC), Pancreatic Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not applicable
56
Wuhan
2025-10-01
Recruiting
To Evaluate the Safety, Tolerability, and Preliminary Efficacy of XH001 Injection as Adjuvant Therapy in Patients With High-risk Recurrent Solid Tumors
NCT07594964Biliary Cancer (Cholangiocarcinoma, Gall Bladder Cancer), Pancreatic Ductal Adenocarcinoma (PDAC), Hepatocellular Carcinoma (HCC), Gastric Cancer (GC)
DrugXH001
Shenzhen Xinhe Biomedical
Phase 1
48
Beijing
2025-08-25
Recruiting
The Possible Range of No.4sb Lymph Node Dissection of Locally Advanced Distal Gastric Cancer
NCT07183150Gastric Cancer (GC), No.4sb
Tianjin Medical University Cancer Institute and Hospital
Observational
400
Tianjin
2025-08-18
Recruiting
Neoadjuvant Radiotherapy Plus Tegafur, Oxaliplatin and Iparomlimab and Tuvonralimab in Resectable Gastric and GE-junction Cancer : A Randomized, Two-arm, Prospective Trial (TRIUNITE-05)
NCT07165847Immunotherapy, Gastric Cancer (GC), Radiotherapy, Neoadjuvant Therapy
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Phase 2
40
Chongqing
2025-07-23
By invitation
PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant Tumors
NCT07023848Breast Cancer, Gastric Cancer (GC), Urothelial Carcinoma (UC)
Affiliated Hospital of Jiangnan University
Phase EARLY_PHASE1
10
Wuxi
2025-07-01
By invitation
Temporal Transformation Mechanism and Intervention Strategies of Frail-related Dietary Behaviors in Older Gastric Cancer Survivors
NCT07176455Gastric Cancer (GC), Frailty in Adult Surgery
Nanjing Medical University
Observational
438
Nanjing
2025-07-01
By invitation
The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Malignancies
NCT07023861Breast Cancer, Gastric Cancer (GC), Urothelial Carcinoma (UC)
Affiliated Hospital of Jiangnan University
Phase EARLY_PHASE1
20
Wuxi
2025-07-01
By invitation
Laparoscopic Staging for Stage III Gastric Cancer
NCT07533825Gastric Cancer (GC), Gastric Adenocarcinoma
Tianjin Medical University Cancer Institute and Hospital
Not applicable
968
Tianjin
2025-02-01
Recruiting
Validating a Medical AI Fine-Tuning Platform for Major Diseases
NCT07795645Chronic Gastritis, Gastric Cancer (GC), Coronary Artery Disease, Stroke
Beijing Friendship Hospital
Observational
96,000
Beijing
2024-11-01
Active, closed
A Study of SYS6010 in Combination With SYH2051 in Patients With Advanced Colorectal Cancer and Other Gastrointestinal Tumors
NCT07104877Colorectal Cancer, Gastric Cancer (GC), Gastrointestinal Tumors
Fujian Cancer Hospital
Not applicable
25
Fuzhou
2024-04-18
By invitation
Prolonged Extubation in Gastric Cancer With OSA
NCT07362706Obstructive Sleep Apnea, Gastric Cancer (GC)
Qilu Hospital of Shandong University
Observational
240
Jinan
2023-01-01
Rows per page Showing 1–23 of 23
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/condition/gastric-cancer-gc

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 23 of those studies listing the condition Gastric Cancer (GC).

How many Gastric Cancer (GC) trials are recruiting in China?

10 of the 23 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 5 have not yet opened recruitment, 2 are active but closed to new participants, and 6 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Gastric Cancer (GC)), 23 studies
PhaseStudiesRecruitingShare
Not applicable7130.4%
Observational6326.1%
Phase 24417.4%
Phase EARLY_PHASE13013%
Phase 3218.7%
Phase 1114.3%

Most active sponsors

Lead sponsors with the most studies (Gastric Cancer (GC))
Lead sponsorStudiesRecruiting
Qilu Hospital of Shandong University31
Affiliated Hospital of Jiangnan University20
Beijing Friendship Hospital22
Tianjin Medical University Cancer Institute and Hospital21
Base Therapeutics (Shanghai) Co., Ltd.10
Cancer Institute and Hospital, Chinese Academy of Medical Sciences11
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University11
Fujian Cancer Hospital10
Jingdong Zhang11
Jinling Hospital, China10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.